AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $36,591 | +750.0% | 54,613 | +445.5% | 0.00% | – |
| Q1 2023 | $4,305 | -59.4% | 10,012 | -70.6% | 0.00% | – |
| Q4 2022 | $10,615 | -37.6% | 34,034 | +17.4% | 0.00% | – |
| Q3 2022 | $17,000 | +13.3% | 28,981 | +52.0% | 0.00% | – |
| Q2 2022 | $15,000 | -78.6% | 19,070 | -74.8% | 0.00% | – |
| Q4 2021 | $70,000 | -4.1% | 75,624 | +109.2% | 0.00% | – |
| Q3 2021 | $73,000 | +15.9% | 36,149 | +43.1% | 0.00% | – |
| Q2 2020 | $63,000 | – | 25,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |